# North American Coral Snake Antivenin (Equine)

NDC: 0008-0423
Generic name: Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)
Labeler / Manufacturer: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20161012

FDA application: BLA101099

## Active ingredients

- CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE): 250 [arb'U]/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0008-0423"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-0423
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d